SCRC hit my screener recently.  I got out back in

SCRC hit my screener recently.  I got out back in October and it looks like I can buy 2x as many shares that I previously had.  I see a lot of recent news in regards to Rapimeds in China and Canada.  Anyone have a detailed analysis of 2014 estimates on Rapimeds and the other revenue sources?  What was the reason for the large decline from the .30s to under teens?

Thanks in advance for any help.

Also interested in other investments if there are any that you guys like.

I can also be reached through PM or email at johnroberts1289@outlook.com